FDA Highlights – by Bruce Sylvester – Patients who received standard therapy for cystic fibrosis plus adjunctive inhaled dry powder mannitol have achieved sustained improvement in lung function… read more.
Scientists have identified 29 new genetic variants linked to multiple sclerosis, providing key insights into the biology of this very debilitating neurological disease. Many of the genes –… read more.
A new study from researchers at Queen Mary, University of London shows how a particular virus tricks the immune system into triggering inflammation and nerve cell damage in… read more.
Multiple sclerosis (MS), a neurodegenerative disease, causes periodic attacks of neurologic symptoms such as limb weakness and mobility defects. And while MS patients’ walking abilities and muscle strength… read more.
by Bruce Sylvester – Stroke patients with a history of stroke or diabetes who received clot-busting drugs post-stroke have achieved better outcomes than those who did not receive… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
